Typical form: N-Acetylcysteine, often paired with Glycine ("GlyNAC")
Used for
NAC is a precursor to glutathione, the body's master antioxidant, which plays a central role in protecting mitochondria from oxidative damage. Most often, it's used here as an adjunct — paired with the mitochondrial-support supplements (CoQ10, PQQ) or with Methyl-Guard for homocysteine — rather than as a first-line answer to one specific marker on its own. The one context where it's used independently is viral illness recovery, where glutathione support and its immune-modulating effects have a direct evidence base of their own.
Common form & typical benefits
What the research says
| Outcome | Approx. evidence base | Typical finding |
|---|---|---|
| Glutathione repletion (GlyNAC combo) | RCT, older adults, 16 weeks | Large improvements in glutathione markers (up to 225%) in a group starting significantly depleted |
| Oxidative stress markers (GlyNAC combo) | Same trial | 42-72% reductions, normalizing to levels seen in younger adults |
| Mitochondrial function, inflammation, muscle strength, cognition (GlyNAC combo) | RCT, older adults, 24 weeks | Broad improvements across multiple aging-related measures; benefits faded after stopping supplementation |
| Long history in respiratory & liver medicine | Decades of clinical use | Well-established safety and mechanism as a glutathione precursor, outside the newer aging-focused research |
| Influenza-like illness (standalone NAC) | RCT, 262 people, mostly 65+, 6 months, 600mg 2x/day | Did not prevent infection itself, but only 25% of infected NAC-treated subjects developed symptomatic illness vs. 79% on placebo; symptom severity/duration also reduced |
An important nuance: the strongest, most striking recent results for mitochondrial and aging-related benefits are for the combination of NAC with glycine (GlyNAC), not NAC alone — worth factoring in when NAC is being used for that adjunct role. The viral-illness evidence, by contrast, is real data for standalone NAC specifically (not paired with glycine), which lines up with how it's used independently here for that purpose.
Research summary chart
View PDF ↗Dosages used in studies
| Goal | Typical dose | Notes | Duration |
|---|---|---|---|
| Practitioner-used dose (this site) | 1,000 mg/day | NAC alone, comfortably within the general supplement range | Ongoing, per practitioner |
| GlyNAC combination trials (research) | NAC + glycine, combined total approaching 10 g/day | Split doses; studied as a pair, not NAC alone | 16–24 weeks |
| General antioxidant/adjunct use (research range) | 600–1,800 mg/day | NAC alone, typical supplement range | Ongoing, per practitioner |
Safety notes & high-dose risks
Additional notes